Integrated Biosciences, Inc.
StreetZero Signal 68
About Integrated Biosciences, Inc.
Integrated Biosciences, Inc. is a biotechnology company that develops next-generation therapeutics for age-related diseases using synthetic biology and machine learning. The company's mission is to rewrite the fundamental biology of aging by translating foundational scientific insights into novel drug development. Founded in 2022, Integrated Biosciences is based in Redwood City, California. The company has made significant progress in its drug discovery engine, with research published in leading journals such as Nature, Nature Aging, and Cell Systems.
LATEST FUNDINGPrivate Placement (Form D)
$68.4M
Announced 2026-08-05
TOTAL RAISED$17.2M
IN THE NEWS
- 🔗 Integrated Biosciences: Funding, Team & Investors | Startup Intros
- 🔗 Integrated Biosciences - 2026 Company Profile & Funding - Tracxn
- 🔗 Integrated Biosciences Nabs $17.2M
- 🔗 Integrated Biosciences Raises $17 Million to Accelerate Development of Drugs Targeting Age-Related Diseases | Longfellow Real Estate Partners
- 🔗 UCSB's Integrated Biosciences Raises $17M Seed Round | UCSB Innovation + Entrepreneurship
EMPLOYEES11-50
FOUNDED2022
HQRedwood City, California, USA
Industry
Biotechnology
Tags
BiotechnologySynthetic BiologyMachine LearningSeed
Investors
Key highlights
- Developing next-generation therapeutics for age-related diseases
- Using synthetic biology and machine learning for drug discovery
- Raised $17.2 million in seed funding from notable investors
Tech stack
Synthetic BiologyMachine LearningAI-driven small-molecule drug discovery
Ask StreetZero about Integrated Biosciences, Inc.
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account